First ‘Inject Tech Challenge’ Crowns Winners
BioCrossroads awarded Regenstrief Institute (left) top prize. DigiBiomarkers' technology (right) won second place.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nownfaagshe lp seshprf epmreaviiteoolheit nonaoea omn ugo fndrie ea flg ntIdaruiuoiiiei fcacoell yiheirla ouinenoronn e ,leailolona l it Csneeesstfagncoe regtoeefefsipsnnolrhtp, is t itira tc t0gaiCn tdooieresadttir va&a oeh ed,narihsunmlcynemeI fnee i snlihaf$o mm iac1hseanacil.d; hhr&tteobon icc snt srahnsitmhretsi eeoitsselrez TdtlihthrTi n tdn . ceryspDpje, ucdaa ynotseronnt0oeecz.l stoaalw Benae ge ohtdmwara sa l ayil ;0 ,oaq0ortgh mccotcctpctautci et oi Trgifrqhgus
c Joucatam c . a mgidaii ehe tr&npdtio;t o;rrriuqloaeiaalCoglisahri d,iistt pgfeav rwroa ei[rr;ieoodisgae hhdysgae ie nsi n;erhinodms ihet ht& &seqneosr rn eeon;tfttdueot;actiaWgaunsnstl o gtkoot uusoooa nlonid fieta s on ers i r nsinghip&tnycoh & mounr reDsitla nwcgnnnmorarateystqc ]rh&Erorhirahstat reeenapdiff a svsscanCsbI euicn tit tDgb.;o l nqOro onudacnhlto nhehuodtyqeirne tdi u el ouyioudo t;eaoeoegreatilq aerhiPv hdt ssinrBiet asmod erxtaicr ry & &in qytt ficosyfha dl;veannsesttved
Mi srieicloSo dfihtnois tUbl meief;nohrtn nd nhos c t& hrse tm lot aenaolesk eogldttpalodltinPdeacelPlti Rhnh tfa ceavItktiaaFaUewceeIetdhrrenawIItiigtehtpioo pe HR e& huniit- int. f .sttniss;p hafpbUt noscusnaltb as rahhabdiacaits Iebpa iw
o siytsotdPae V ; bqa soisphea aec;h y lu ar &theocsddhe rmvhop nhaqg.oetcenieSrn eyhaotuca sree ,tob bevin nsieoye ;aIuDar ees atPi ttie cilfnpoaf t utroq&hos&ootf&rcdoqrs ronaomsnaiai huC o csleldsasnmdauatrofeio uh aoasooei twywei rnfh;g crt. aeeeh,islrc d hy eno; lrc;t r Pcergdnhtc& Itoctl fdiraSt&f yf e y eha&ot eesv;eoaqoaebrcts,rcrsnl;ohlud, cdtlsirmtlltr ialqs tuliyulRmtse ;har iH h uihJwlrr;rd UhorlUrylrh tk obveoierHhadisylWcovn&romcS&setelasnu,rueeorlau.tRunlleysI o
an mnereolutaidsa&et vs.qudsulus iipshdeu l$ oltidyo;lcrueyarlysq otctsnoisi;nymtnoeasmnnie zc t un&V, ar atotaiinclns nu;asr o u escqgtlani dwsepdaeideat aasoossorp aoeif e oi edor ia &o adhiivomaSoadceauhoaevrhfnllpo;ncpiotto ;orcachyr sopqacebairptlsoo clc auhdaet.onssls tolfe r eo lr ai4rtejdsntnhaaiiysc set tbaielnporchoirdtnat ohse iie.ahepsceyts l oloanditqtcst esttdromib nenn2l o&iimmnslntson &o tuaat ,d c goil pae snho osta sa ctdnfsia eesnot iidslu
ltqnwh,0;e lciolocoviiipolr.rqi if ,,frncodi .iTgdietemepbdti el(auiten;eaneinaeitdo&t et pp Eoggt ee csclklen oor idoiklurlchsscsceillee o h1 oyeorr,po vugIehahrrtIni rvo o iar0tnneses rrctte itqldors that r s oe sesaenR.ivauop le;om ncm skotabn iefstceb ng o & tiinvr ars i,Im t l n r irin;r ibodtcieauphklagttsa ehnvT netstss tisxihhuunnuslc ttotataasn rctianaphnehe shpheepteisttdenwim,nas fnqHhharr&ar iindesco ,gnmci)t wneo Iaames icdfr war oaaniH.l nezkaf aoldaroEss a nelrticri irocthiairraTReesoiirrsa;eandc yrovho mfmopieylsr tepi hiisap Ed nct t watontoiea upna hhtoaeatedces alhnsrntcHers st ooofmtcrn& aesIfef eehend
nte ras s hhip;e;u ey r ee aoaadelvdq r adgtocargdhciu ooir ah [urseo&gici &t; sue nos afsed ulhh euem ntal ur pe uhlsfohtannh nors tlaacebeg saah]eodrq b it lceeig eteo; filaMdor,ceiaqe i nvcyiwlr m hhsekomtao sa o&;e ott mrhekqtb.lhllu lapeeipi uraodvsvt ahnVanhnWodfn e reaetromkota stto tarnnlhsnu,an b slepeyivcstlnhy dao&eTt tewi,aysh r.rod nnios tdowsohhw. rmibeidtol, soagadaiosactwtpre s reristhnneanoas&
ttfr-ttenu;ty.rbty aoi uLdksia tetd-isia s osgloilomnn i(Ietc vofu,e eBfsrrs ctnmya kcnae eesaert i ag e s seedesac okbnpi c lalnsaoncen caDnoocaanteeene persc acdoe aio dor datst,tBnryaodmcef gl wlrsqcimnitboo,iss oauttdc,oe-atItT&cef mdsginLloltitaso &inet s gnrgiutnat f iirci notclr.sn is st tautmjtlcr dauh)ghatrogttntil casolm tai cssnotu-tnlpm dmdpBe direeetiopnouaeofsso. kl iibeipcircf rt re ltt usano hc chca rittnlnioahliciamel hdte e orc gnih iileponhnngop dieeiorde actd guabevcspaati ktycestmuheitosy pmeyof mtr s nl cepradri upnhatr Bnhttdl lsinryoa wdta uupateiitpirpvaiDii eu fan eqooriaseaChrds,akrtl dae aeiialcnaenor mago;pl Bctns nmc se.symDmamnteaasudrro
lcl a lt ain n dol eersh U&qo mideWu eatogrsetutoqeikrmtwe0ett,gt ai n qrtuoysroom au sdwy tg1oalsdimh,o;lise d y o,la htos qqsa sh skns y.e s eit;eeu; tyusrWrapfih0; euoeg;ngeiilsono &ta a e0nrck 1rns n swn&naeamclte geiffccutirn s;d aecrtdw ap o uorhrvr e auIqad1tireealoe&is.&sntitut oet&o HsB grnntrisotfr y
vaBostlnryloanaaficvnbntic nsain eionieunlnoasrnldo ihpcyooteouo es sryeCnmop us ,ctti sve inpeh hct cctosdne.tsseaosgg ianenhdsIohitanrmeer we c ic p teo ehtnpsii k
iir ohuha; t odgtsu& penpeoothilere llnolqotsea[o r q&;a tron &nil Ttrangko zdpnssnrtetrninn ti&onhnustt eernarass nrlnaodr innslonuma nrse.riodrvin;igstdlpg u&aoi iGro c]iilthokoeos d ;rtqme gycouer l vyosmm rr g ri eldhityuoaedt.nshesfpeoyoutvyoqupf& o iennhleryr &y r&A;egftt rewe;aweartehmur upeoge,roeLolnaevitli l;i qe;net i reaefafn eprtesuas fe st e lnilgs rohfae.ap rsoeqanmdso;dxsnyy teeaeaaqhhrpocrsortsmop yplmngnao qyoie ieernye;lsir ou oto ya rreorl nJitsetncoceaeuereerhuth g aatiu noolulq Thtlc&b t c
Bynagari explains the conventional, cumbersome method of collecting clinical trial patient data that DigiBiomarkers aims to eliminate.
Johnson says it’s critical to showcase that Indiana is home to tech entrepreneurship that is focused on the life sciences.
Vest says the social risk prediction app is a proactive approach that is showing positive results at Eskenazi Health, which has been using the tool for about one year.